Let’s see if this selloff is just another one day wonder or something more.
On Today’s Calendar:
- 10:30 — Crude Inventories
More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
Gapping down on weak earnings/guidance: VTAL -24.3%, CPWR -17.8%, HITK -6.2%, RYL -4.7%, INFY -2.3%… Other news: DNDN -6.1% (disclosed the SEC is conducting an informal probe related to the clinical trials for Provenge), ANAD -3.0% (downgraded to Neutral at Credit Suisse), JSDA -3.0% (still checking), JASO -2.8% (downgraded to Hold at Needham), ATVI -1.6% (downgraded to Neutral at JP Morgan).
Gapping Up
Gapping up on strong earnings/guidance: ACGY +8.3%… M&A: BCGI +70.9% (to be acquired by Megasoft for $3.60 per share), CHAP +10.5% (to be acquired by Gerdau Ameristeel for $86.00 per share)… Other news: TRCA +22.7% (announces agreement with Genentech for worldwide growth hormone and IGF-1 combination product development and commercialization), ASYS +13.5% (announces $4.4 mln additional new solar orders), PXG +12.8% (awarded $100 mln DoD contract), SGMO +6.6% (co and SIAL announce alliance to develop zinc finger-based laboratory research reagents), NOVC +5.1% (receives $60 mln under SGP agreement for Asentar), CTIC +5.1% (co announced pixantrone combination therapy for first-line treatment of NHL results in reduction in severe toxicities), RKT +4.7% (upgraded to Buy at Deutsche Bank), UN +3.5% & UL +3.1% (Bloomberg.com reports UL/UN shares rise overseas on speculation of possible Colgate offer), AZN +3.0% (upgraded to Overweight at Morgan Stanley), SNDK +1.8% (tgt upped to $60 at Piper).
Disclaimer & How I use this list
